Meridian Bioscience Stock

Meridian Bioscience PP&E per Employee

The PP&E per Employee of Meridian Bioscience (VIVO) as of Sep 11, 2026 is 76,830.30 USD. In the previous year, PP&E per Employee was 74,242.42 USD — a change of 3.49% (higher).

PP&E per Employee

76,830.30USD

YoY

3.49%

Last updated:

PP&E per Employee of Meridian Bioscience is 2026 76,830.30 USD. PP&E per Employee of Meridian Bioscience was 2025 74,242.42 USD. It decreases by 3.49% higher compared to the previous year.

The Meridian Bioscience PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2015
41,666.67 USD
Jan 1, 2016
46,212.12 USD
Jan 1, 2017
46,212.12 USD
Jan 1, 2018
45,454.55 USD
Jan 1, 2019
46,363.64 USD
Jan 1, 2020
56,818.18 USD
Jan 1, 2021
74,242.42 USD
Jan 1, 2022
76,830.30 USD
The Meridian Bioscience PP&E per Employee history
YEARPP&E per EmployeeYoY
76,830.30USD+3.49%
74,242.42USD+30.67%
56,818.18USD+22.55%
46,363.64USD+2.00%
45,454.55USD-1.64%
46,212.12USD0.00%
46,212.12USD+10.91%
41,666.67USD-0.36%
41,818.18USD
Access this data via the Eulerpool API

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

PP&E per Employee of Meridian Bioscience is 76,830.30 USD in 2026.

PP&E per Employee of Meridian Bioscience changed from 74,242.42 USD to 76,830.30 USD, representing a 3.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Meridian Bioscience historically and in real time.

Access this data via the Eulerpool API

Workforce — Meridian Bioscience

All Key Metrics — Meridian Bioscience